A randomized controlled clinical study on the efficacy of Chinnadi Kashaya in Amlapitta (Chronic Gastritis)

Nearly 25–30% of Indians suffer from Amlapitta or chronic gastritis. In this open-label, randomised clinical study, the effectiveness of Patoladi Kwatha and Chinnadi Kashayam in treating Amlapitta (chronic gastritis) was studied. Heartburn, nausea, and indigestion are some of the symptoms of Amlapitta, a disorder associated with the vitiation of Pitta dosha brought on by unhealthy eating and lifestyle choices. Two groups of forty Amlapitta patients were formed: For 30 days, Group B received Patoladi Kwatha, while Group A received Chinnadi Kashaya. When compared to Patoladi Kwatha, observations revealed that Chinnadi Kashaya had considerably reduced symptoms such as bloating, acid reflux, and indigestion. On the other hand, Patoladi Kwatha was far more effective in lowering appetite loss and fatigue. With each formulation providing distinctive benefits, these results offer credence to the therapeutic implementation of Ayurvedic medicines in the management of disorders like gastritis. The study demonstrates the therapeutic potential of both Ayurvedic formulations in treating digestive diseases, primarily Amlapitta, and indicates that Chinnadi Kashaya may provide superior overall comfort. Both formulations exhibited no adverse reactions. The long-term consequences and possible combinations of these medicines need to be investigated further.